~~<i id='2DB1767A87'><strike id='2DB1767A87'><tt id='2DB1767A87'><pre id='2DB1767A87'></pre></tt></strike></i>~~

Home» explore» leisure time

leisure time

author：knowledge 2025-09-27 12:04:11 Page View：9

Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Russian court extends detention of American musician
Next article： Virginia high school admissions case could be legal follow

knowledge

ChatGPT in medicine: STAT answers readers' burning questions

MikeReddyforSTATArtificialintelligenceisoftendescribedasablackbox:anunknowable,mysteriousforcethatop

Court strikes down limits on filming of police in Arizona

FILE-PhoenixPolicestandinfrontofpoliceheadquartersonMay30,2020,inPhoenix,waitingforprotestersmarchin

Activists slam private health insurers over coverage restrictions

ProtestorsoutsideAmerica'sHealthInsurancePlansheadquarters.CourtesyPeople'sActionWASHINGTON—Hun

HIPAA doesn't protect reproductive records from prosecutors

HyacinthEmpinado/STATWithRoev.Wadenowoverturned,patientsarewonderingwhetherfederallawswillshieldthei